Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
Atefeh Fakharian, Saghar Barati, Maryam Sadat Mirenayat, et al.
International Immunopharmacology (2021) Vol. 99, pp. 107961-107961
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 47
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
The Immunopathogenesis of a Cytokine Storm: The Key Mechanisms Underlying Severe COVID-19
Luka Hiti, Tijana Markovič, Mitja Lainščak, et al.
Cytokine & Growth Factor Reviews (2025)
Open Access | Times Cited: 6
Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments
Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 55, Iss. 2, pp. 154-167
Closed Access | Times Cited: 63
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
Gerasimos Evangelatos, Giorgos Bamias, George D. Kitas, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1493-1511
Open Access | Times Cited: 63
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Realigning the LIGHT signaling network to control dysregulated inflammation
Carl F. Ware, Michael Croft, Garry A. Neil
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 7
Open Access | Times Cited: 39
Aprotinin—Drug against Respiratory Diseases
Alexandre V. Ivachtchenko, Andrey A. Ivashchenko, Dmitrii O. Shkil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11173-11173
Open Access | Times Cited: 11
Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials
Zhenchao Wu, Zhifei Han, Beibei Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury
Guilherme Pasetto Fadanni, João Β. Calixto
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 13-25
Closed Access | Times Cited: 10
COVID-19 Pneumonia and Cytokine Storm Syndrome
Frank L. van de Veerdonk
Advances in experimental medicine and biology (2024), pp. 307-319
Closed Access | Times Cited: 3
Pathophysiological mechanisms of ARDS: a narrative review from molecular to organ-level perspectives
Kaihuan Zhou, Qianqian Qin, Junyu Lu
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Predictive Factors for COVID-19 Severity in Patients with Axial Spondyloarthritis: Real-World Data from the Romanian Registry of Rheumatic Diseases
Andreea-Iulia Vlădulescu-Trandafir, Violeta‐Claudia Bojincă, Cristina Raluca Gh. Popescu, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 411-411
Open Access
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response
Ivan Gur, Amir Giladi, Yonathan Nachum Isenberg, et al.
Acta Haematologica (2022) Vol. 145, Iss. 3, pp. 297-309
Open Access | Times Cited: 15
SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
Hongyu Liang, Yuyan Wu, Vicky Yau, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1538-1538
Open Access | Times Cited: 15
An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 8
Progress in cytokine research for ARDS: A comprehensive review
Kaihuan Zhou, Junyu Lu
Open Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review
Hebah Alhajeri, Fatemah Baroun, Fatemah Abutiban, et al.
Postgraduate Medicine (2022) Vol. 134, Iss. 2, pp. 160-179
Open Access | Times Cited: 14
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14340-14340
Open Access | Times Cited: 11
Update on Remdesivir in the Treatment of Novel Coronavirus Pneumonia
Feng Huang, K. Vijaya Lakshmi, Chin Tat Ng, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Heart Failure Relapses in Response to Acute Stresses – Role of Immunological and Inflammatory Pathways
Lisa Hasselbach, Johannes Weidner, Albrecht Elsässer, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Effect of anti-inflammatory drugs on the storm of inflammatory factors in respiratory tract infection caused by SARS-CoV-2: an updated meta-analysis
Zhiping Qin, Yongbiao Li, Wenjing Sun, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019
Jing Wang, Xuedong Yin, Linlin Yu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 2
Randomized trial drug controlled compendious transcriptome analysis supporting broad and phase specific therapeutic potential of multiple candidates in COVID-19
Abhay Sharma
Cytokine (2021) Vol. 148, pp. 155719-155719
Open Access | Times Cited: 5
Efficacy of COVID‐19 Treatments in Intensive Care Unit: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Mahmoud Alwakeel, Francois Abi Fadel, Abdelrahman Nanah, et al.
Critical Care Research and Practice (2024) Vol. 2024, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top